This study explored treatment strategies targeting EGFRvIII-mutated GBM and investigated the effects of targeted regulation of the MDK signaling pathway on tumor growth, prognosis, and the immune microenvironment in a mouse model of intracranial glioma. This evidence concerns the gene MDK and neoplasm.